RESUMO
BACKGROUND: Loss-of-function homozygous or compound heterozygous mutations in IL36RN, which encodes interleukin-36 receptor antagonist (IL-36Ra), has been implicated in the pathogenesis of skin disorders. However, the pathogenic role of IL-36Ra in cutaneous ischemia-reperfusion (I/R) injury remains unclear. OBJECTIVES: We investigated the role of IL36Ra in cutaneous I/R injury. METHODS: We examined I/R injury in Il36rn-/- mice. The area of wounds, numbers of infiltrated cells, apoptotic cells and neutrophil extracellular trap (NET) formation were assessed. The expression levels of various genes were analysed using real-time RT-PCR. The expression of high mobility group box 1 (HMGB1), an endogenous toll-like receptor (TLR) 4 ligand, was confirmed using immunohistology, and serum HMGB1 levels were measured by ELISA. Cytokine production by stimulated cultured J774A.1 and HaCaT cells was examined. RESULTS: IL-36Ra deficiency resulted in significantly delayed wound healing and increased neutrophil and macrophage infiltration into the wound tissues. Il36rn-/- mice had increased mRNA expression levels of CXCL1, CXCL2, CCL4, TNF-α, TGF-ß, IL-1ß, IL-6 and IL-36γ relative to wild-type mice. Apoptosis was identified in keratinocytes by TUNEL assay. HMGB1 expression in the I/R site was decreased in both keratinocytes and adnexal cells, while serum HMGB1 levels were significantly elevated after reperfusion. The mRNA levels of various cytokines, including IL-1ß, were elevated in J774A.1 cells through TLR4 signalling by HMGB1 stimulation. In addition, HaCaT cells stimulated with IL-1ß showed significantly increased CXCL1, TNF-α, IL-6, IL-36ß and IL-36γ mRNA expression. Furthermore, NET formation was increased by IL-36Ra deficiency. Finally, either the blockade of TLR4 signalling by TAK-242 or inhibition of NET formation by Cl-amidine normalized exacerbated I/R injury in Il36rn-/- mice. CONCLUSIONS: This study indicated that IL-36Ra deficiency exacerbates cutaneous I/R injury due to excessive inflammatory cell recruitment, NET formation, and excessive cytokine and chemokine production via the TLR4 pathway by HMGB1 released from epidermal apoptotic cells.
Assuntos
Proteína HMGB1 , Traumatismo por Reperfusão , Animais , Citocinas , Proteína HMGB1/genética , Proteína HMGB1/metabolismo , Macrófagos/metabolismo , Camundongos , Traumatismo por Reperfusão/genética , Transdução de Sinais , Fator de Necrose Tumoral alfaAssuntos
Genes Dominantes/genética , Lentigo/genética , Proteínas Proto-Oncogênicas c-kit/genética , Idoso de 80 Anos ou mais , Biópsia , Análise Mutacional de DNA , Progressão da Doença , Feminino , Humanos , Japão , Lentigo/patologia , Masculino , Mutação de Sentido Incorreto , Linhagem , Pele/patologia , Sequenciamento do ExomaAssuntos
Neoplasias Cutâneas/complicações , Carcinoma de Células Escamosas de Cabeça e Pescoço/complicações , Fatores de Transcrição/genética , Síndromes de Tricotiodistrofia/complicações , Síndromes de Tricotiodistrofia/genética , Adulto , Humanos , Masculino , Pescoço , Neoplasias Cutâneas/genética , Carcinoma de Células Escamosas de Cabeça e Pescoço/genéticaAssuntos
Doenças da Aorta/genética , Hipoplasia do Esmalte Dentário/genética , Helicase IFIH1 Induzida por Interferon/genética , Metacarpo/anormalidades , Doenças Musculares/genética , Mutação de Sentido Incorreto/genética , Odontodisplasia/genética , Osteoporose/genética , Calcificação Vascular/genética , Doenças da Aorta/patologia , Pré-Escolar , Hipoplasia do Esmalte Dentário/patologia , Feminino , Humanos , Metacarpo/patologia , Doenças Musculares/patologia , Odontodisplasia/patologia , Osteoporose/patologia , Polimorfismo de Nucleotídeo Único/genética , Calcificação Vascular/patologia , Sequenciamento do ExomaRESUMO
Patients with deficiency of interleukin-36 receptor antagonist (DITRA), due to mutation of IL36RN, exhibit psoriatic phenotypes, typically generalized pustular psoriasis (GPP). We report a paediatric patient with DITRA, whose cutaneous lesions varied from psoriasis vulgaris in infancy to annular pustular psoriasis with acute exacerbation to GPP at 13 years of age. Conventional systemic treatments for GPP, which include oral retinoids, ciclosporin and methotrexate, are controversial in paediatric cases, because of their adverse effects and uncertain long-term consequences. Granulocyte monocyte apheresis, a process associated with few adverse events, promptly controlled the GPP of our paediatric patient, and has potential as a suitable alternative treatment for paediatric patients with DITRA.
Assuntos
Citaferese/métodos , Granulócitos , Interleucinas/genética , Monócitos , Psoríase/terapia , Adolescente , Humanos , Masculino , Mutação/genética , Psoríase/genética , Resultado do TratamentoRESUMO
OBJECTIVES: To estimate the annual prevalence of different diagnostic categories by age, breed and sex in insured cats in Japan for which veterinary care claims had been made, and to identify if there is a pattern in these host factors. MATERIALS AND METHODS: Data from 48,187 cats insured for veterinary care in Japan in the period from April 2012 to March 2013 comprising 26,003 males and 22,184 females were analysed to calculate the annual prevalence of 18 diagnostic categories of disease by age, breed and sex. RESULTS: The prevalence was highest for urinary system disorders (12·2% for males and 10·0% for females), followed by digestive disorders (11·6% for males and 10·7% for females) and dermatological diseases (8·7% for males and 9·0% for females). The male cats had a higher prevalence than female cats for most diagnostic categories. The prevalence of cardiovascular, urinary, endocrine and neoplastic disorders increased with age; infectious and parasitic diseases had high prevalence at young ages, and the prevalence of respiratory, musculoskeletal disorders and injuries had bimodal peaks. Dermatological disorders had a high prevalence at all ages. A large variation in prevalence was observed between breeds for otic, dermatological, dental and cardiovascular disorders. CLINICAL SIGNIFICANCE: The findings can be used to increase awareness of patterns of health disorders in different categories of cat.
Assuntos
Doenças do Gato/epidemiologia , Distribuição por Idade , Animais , Doenças do Gato/genética , Gatos , Feminino , Japão/epidemiologia , Masculino , Prevalência , Distribuição por Sexo , Especificidade da EspécieRESUMO
Here we report a rare case of neutrophilic dermatoses related to a granulocyte colony-stimulating factor (G-CSF)-producing solid pseudopapillary tumour (SPT). The patient was a 39-year-old woman presenting with scattered pustules and crusts of the palms, heels and thighs and plaques of the bilateral lower legs. The skin biopsy revealed dense neutrophil infiltration in the epidermis to the dermis. A pancreatic head tumour was detected using computed tomography. A pathological examination of the resected specimen suggested an SPT. As the skin eruption promptly disappeared after SPT resection, we hypothesized that SPT secretes growth factors including epidermal growth factor (EGF) and G-CSF. The SPT cells stained positive for both EGF and G-CSF tumour cells. The serum levels of interleukin (IL)-6 and IL-10 and tumour necrosis factor-α were within normal limits before and after the SPT resection. In contrast, the serum IL-8, EGF and G-CSF levels decreased after the SPT resection. This is a rare case of neutrophilic dermatoses related to a G-CSF-producing SPT. The present case suggests that physicians should be aware that a G-CSF-producing tumour is a differential diagnosis to consider in patients with unusual aseptic pustulosis.
Assuntos
Carcinoma Papilar/complicações , Fator Estimulador de Colônias de Granulócitos/biossíntese , Neoplasias Pancreáticas/complicações , Dermatopatias/etiologia , Adulto , Feminino , Humanos , Perna (Membro)Assuntos
Proteínas Adaptadoras de Transporte Vesicular/genética , Envelhecimento/genética , DNA/genética , Mutação da Fase de Leitura , Ceratodermia Palmar e Plantar/genética , Pele/patologia , Proteínas Adaptadoras de Transporte Vesicular/metabolismo , Biópsia , Análise Mutacional de DNA , Humanos , Ceratodermia Palmar e Plantar/diagnóstico , Ceratodermia Palmar e Plantar/metabolismo , Masculino , Pessoa de Meia-Idade , Linhagem , FenótipoRESUMO
Leukemia inhibitory factor (LIF) is a cytokine which is essential for oocyte and embryo development, embryonic stem cell, and induced pluripotent stem cell maintenance. Leukemia inhibitory factor improves the maturation of oocytes in the human and the mouse. However, feline LIF (fLIF) cloning and effects on oocytes during IVM have not been reported. Thus, we cloned complete cDNA of fLIF and examined its biological activity and effects on oocytes during IVM in the domestic cat. The aminoacid sequence of fLIF revealed a homology of 81% or 92% with that of mouse or human. The fLIF produced by pCold TF DNA in Escherichia coli was readily soluble and after purification showed bioactivity in maintaining the undifferentiated state of mouse embryonic stem cells and enhancing the proliferation of human erythrocyte leukemia cells. Furthermore, 10- and 100-ng/mL fLIF induced cumulus expansion with or without FSH and EGF (P < 0.05). The rate of metaphase II oocytes was also improved with 100-ng/mL fLIF (P < 0.05). We therefore confirmed the successful production for the first time of biologically active fLIF and revealed its effects on oocytes during IVM in the domestic cat. Feline LIF will further improve reproduction and stem cell research in the feline family.
Assuntos
Gatos/fisiologia , Escherichia coli/metabolismo , Fator Inibidor de Leucemia/metabolismo , Sequência de Aminoácidos , Animais , Sequência de Bases , Clonagem Molecular , DNA Complementar , Embrião de Mamíferos/citologia , Fibroblastos/fisiologia , Regulação Bacteriana da Expressão Gênica/fisiologia , Fator Inibidor de Leucemia/genética , PlasmídeosAssuntos
Autoanticorpos/metabolismo , Neoplasias da Mama/complicações , Dermatomiosite/imunologia , Doenças Pulmonares Intersticiais/complicações , Fatores de Transcrição/imunologia , Autoanticorpos/imunologia , Dermatomiosite/complicações , Dermatomiosite/metabolismo , Feminino , Humanos , Pessoa de Meia-Idade , Fatores de Transcrição/metabolismo , Dedos de ZincoRESUMO
The life expectancies and causes of death were evaluated in 299,555 dogs insured in Japan between 1 April 2010 and 31 March 2011, of which 4169 dogs died during this period. The overall life expectancy of dogs was 13.7 years. The probability of death was high in the first year of life, lowest in the second and third years, and increased exponentially after 3 years of age. The life expectancy was 13.8 years in the <5 kg body weight group, 14.2 years in the 5-10 kg body weight group, 13.6 years in the 10-20 kg body weight group, 12.5 years in the 20-40 kg body weight group and 10.6 years in the ≥40 kg body weight group. As body weight increases, life expectancy tended to decrease except in the <5 kg body weight group. The probability of death increased as dogs got older for most potential causes of death. Neoplasia resulted in the highest probability of death, especially in the large and giant breed groups. Cardiovascular system disorders were the second major cause of death and the toy group had a probability of death significantly higher than the other breed groups at age 12+.
Assuntos
Causas de Morte , Doenças do Cão/mortalidade , Tábuas de Vida , Animais , Doenças do Cão/etiologia , Cães , Feminino , Seguro/estatística & dados numéricos , Japão/epidemiologia , MasculinoRESUMO
We calculated the annual prevalence of diseases of 18 diagnostic categories in the insured dog population in Japan, using data from 299,555 dogs insured between April 2010 and March 2011. The prevalence was highest for dermatological disorders (22.6% for females and 23.3% for males), followed by otic diseases (16.4% for females and 17.2% for males) and digestive system disorders (15.7% for females and 16.4% for males). The prevalence of cardiovascular, urinary, neoplasia and endocrine disorders, increased with age; infectious diseases and injuries showed a high prevalence at young ages, and the prevalence of musculoskeletal and respiratory disorders showed a bimodal peak at young and old ages. A large variation in prevalence was observed between breeds for dermatological, otic, digestive, ophthalmological and cardiovascular disorders.
Assuntos
Doenças do Cão/epidemiologia , Distribuição por Idade , Animais , Doenças do Cão/etiologia , Doenças do Cão/genética , Cães , Feminino , Japão/epidemiologia , Masculino , Prevalência , Especificidade da EspécieRESUMO
Lupus erythematosus profundus (LEP), which is a variant of chronic cutaneous lupus erythematosus (CLE), is seen in approximately 2â¼3% of CLE patients, and only 10% to 20% of LEP patients present with systemic LE (SLE). LEP shows subcutaneous nodules with or without discoid LE (DLE). Linear LEP, a very rare variant of LEP, was first reported in 1991 in Japanese and in 1998 in English. Since LEP sometimes leaves skin depressions or scars as a result of atrophy of adipose tissue, early and adequate treatments are necessary. Here, we introduce an LEP case in which magnetic resonance imaging (MRI) was quite effective in evaluating a lesion that had been considered to be linear DLE.
Assuntos
Lúpus Eritematoso Discoide/patologia , Lúpus Eritematoso Sistêmico/patologia , Paniculite de Lúpus Eritematoso/patologia , Adulto , Anti-Inflamatórios/administração & dosagem , Anticorpos Antinucleares/análise , Biópsia , Feminino , Seguimentos , Humanos , Japão , Lúpus Eritematoso Discoide/tratamento farmacológico , Lúpus Eritematoso Sistêmico/tratamento farmacológico , Imageamento por Ressonância Magnética/métodos , Paniculite de Lúpus Eritematoso/tratamento farmacológico , Paniculite de Lúpus Eritematoso/metabolismo , Prednisolona/administração & dosagemAssuntos
Fucosiltransferases/genética , Hiperpigmentação/diagnóstico , Mutação/genética , Dermatopatias Genéticas/diagnóstico , Dermatopatias Papuloescamosas/diagnóstico , Adolescente , Adulto , Idade de Início , Diagnóstico Diferencial , Glucosiltransferases/genética , Heterozigoto , Humanos , Hiperpigmentação/genética , Pessoa de Meia-Idade , Linhagem , Dermatopatias Genéticas/genética , Dermatopatias Papuloescamosas/genética , Adulto JovemRESUMO
BACKGROUND: Nagashima-type palmoplantar keratosis (NPPK) is a distinct autosomal recessive genodermatosis characterized by diffuse transgressive palmoplantar keratoderma (PPK). Very recently, putative loss-of-function mutations in SERPINB7, which encodes a member of the serine protease inhibitor superfamily and is abundantly expressed in the epidermis, have been identified as a cause of NPPK. OBJECTIVES: To confirm further the role of SERPINB7 mutations in the pathogenesis of NPPK. METHODS: We analysed 10 Japanese families with NPPK using Sanger and/or whole-exome sequencing. RESULTS: We identified one novel and three recurrent null mutations in SERPINB7. In all the families, the NPPK trait was inherited in an autosomal recessive manner; in one of the families, there was pseudodominant inheritance, which had not been described in NPPK. CONCLUSIONS: These data clearly provide further evidence that NPPK is caused by loss-of-function mutations in SERPINB7.